Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Dec 17, 2021 1:08pm
105 Views
Post# 34241259

RE:RE:RE:RE:RE:RE:RE:RE:About the share price today...

RE:RE:RE:RE:RE:RE:RE:RE:About the share price today...Aarcor said, "BTI's share price is entirely dependent on it's management's ability to deliver on promises and generate business."

Good one. You probably clipped that out of one of the hundreds of posts where I've said the same thing.

Duh...!

As far as the forum having an impact goes, it certainly does have an impact. WTF, are you nuts? I deal with the effects of comments on this forum every day. It has a huge effect on shareholder attitudes, arguably a greater impact than DrDR's own words and the company's news. The former is negative, the latter is positive and we still have a share price of 25¢. QED.

Ron Rydell, I think you're wrong. You think I'm wrong. That's what makes a market.

chrispi - agree with some stuff you said but as we have discussed, I think you're wrong about a lot.

I find it hard to believe that DrDR and the BoD announced yesterday that Bioasis has failed and is being placed for sale. The abandonment of a pipeline that in the AGM was described as variously having the potential to produce 3 and 4 billion per year with already-proven drugs (Herceptin and Avastin) and with several recent new collaborations, is something that defies logic.

The AGM could not have produced a more poor result. The resounding opinion, here and in private, are negative. I really don't think that I could so poorly understand what was presented at the AGM. Time will tell.

jd

<< Previous
Bullboard Posts
Next >>